Companies /Healthcare

Haemonetics Corp

NYSE: HAE Medical Devices
$102.86
▲ $0.01 (+0.01%) today
Markets open · 1:21pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$4.7B
P/E Ratio
49.7
Profit Margin
7.1%
Revenue (TTM)
$1.4B
EPS (TTM)
$2.07
52-Week Range
$47 – $110
Street Target
$106.40

About Haemonetics

Haemonetics Corp is a global healthcare company specializing in innovative blood management solutions. It offers a wide range of products, including automated plasma collection systems, blood component and manual whole blood collection systems, and advanced software for managing donor information and blood supplies. Additionally, Haemonetics provides hospital products like hemostasis analyzer systems for assessing patient hemostasis and autologous blood recovery systems used in various surgeries. With a focus on improving patient care and safety, the company serves healthcare providers through a combination of direct sales and distributors. Founded in 1971, Haemonetics is headquartered in Boston, Massachusetts.

HAE Coverage

8:50am ET
Investing

Wednesday’s Top Analyst Upgrades and Downgrades: Applied Materials, CrowdStrike, First Solar, Newmont, Occidental Petroleum, Palo Alto Networks, Take-Two Interactive, Twilio, Zscaler and More

Wednesday's top analyst upgrades and downgrades included Ally Financial, Applied Materials, CrowdStrike, Fidelity National Information Services, First Solar, Fortinet, Newmont, Occidental Petroleum, Palo Alto Networks, Take-Two Interactive Software, Trade Desk, Twilio and…

Lee Jackson